Floatz logo

CLOMIPHENE CITRATE

Ovulation Induction

University Hospital, GhentSmall moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Ovulation Induction cohort.

Asset / SponsorPhaseRating
Follitropin Alpha
Merck KGaA, Darmstadt, Germany
Phase 4A
Folic Acid
University Hospital, Ghent
Phase 4BB
Inositol
University Hospital, Ghent
Phase 4BB
FOLLITROPIN BETA
Merck KGaA, Darmstadt, Germany
Phase 3BB
Urofollitropin
Merck KGaA, Darmstadt, Germany
Phase 3BB

View all 10 →

Same molecule, other indications

CLOMIPHENE CITRATE is also rated in:

infertility disorderDormant
A
Indicative ·
81 / 100
View asset →
anovulationDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →